A case of sequential medical therapy for advanced ureteral cancer in Li–Fraumeni syndrome

A case of sequential medical therapy for advanced ureteral cancer in Li–Fraumeni syndrome

Introduction Li–Fraumeni syndrome, an autosomal dominant cancer predisposition syndrome caused by a pathogenic variant of TP53, a tumor suppressor gene, leads to a high risk from early childhood of developing various types of cancers. Here, we report a case of advanced ureteral cancer in Li–Fraumeni...

Full description

Bibliographic Details
Main Authors: Minami Une, Ryo Fujiwara, Arisa Ueki, Ryosuke Oki, Tetsuya Urasaki, Kentaro Inamura, Shunji Takahashi, Junji Yonese, Takeshi Yuasa
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:IJU Case Reports
Subjects:
advanced urothelial cancer
avelumab
immune checkpoint inhibitor
Li–Fraumeni syndrome
TP53 pathogenic variant
Online Access:https://doi.org/10.1002/iju5.12607

Internet

https://doi.org/10.1002/iju5.12607

Similar Items